What You Should Know:
- Medtronic announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) – and the presentation of AccuRhythm AI validation data this week at Heart Rhythm 2021.
- AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart
Read More
Cardiac Monitoring
Could ‘Hospitals Without Walls’ Be the New Normal for Telehealth and Remote Patient Monitoring?
The statistics surrounding the COVID-19 pandemic continue to be startling, despite the ever-growing mental and physical fatigue that we’ve all experienced living through this frightening, intimidating and unprecedented era. More than 125 million cases worldwide have resulted in a death toll closing in on three million, while in the United States alone, 30 million reported infections have resulted in a death toll that reached 550,000. (1) One thing that can be said for certain about
Read More
The Future of Remote Care Automation Begins with Cardiac Rehabilitation
2020 was undeniably the year that saw telehealth and remote care services come to the forefront of medical care. Many have hypothesized that, in the post-COVID world, remote care programs will be ubiquitous throughout hospitals and health systems. However, such a future is far from certain, as too many organizations currently lack the budget, IT infrastructure, and time necessary to implement new innovative remote care programs. There is a considerable disparity between the hype surrounding
Read More
How Will Philips Acquisition of BioTelemetry Impact The Cardiac Monitoring Market?
At the end of December 2020, Philips announced the planned acquisition of BioTelemetry for $2.8 billion in cash.
- BioTelemetry was formed in 2013 after a series of acquisitions from the initial founding company CardioNet, Inc.
- CardioNet, Inc. based in San Diego, USA was initially founded in 1994.
- After a multitude of acquisitions in recent years, BioTelemetry has established itself as a leading cardiac powerhouse, specializing in mobile and wireless medical technology. After this
Read More
Casana Raises $14M to Expand IoT Heart Health Toilet Seat
What You Should Know:
- Casana raises $14M in Series A funding to pursue FDA clearance for its an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output.
Casana, previously known as Heart Health Intelligence, Inc., a healthcare technology firm that is re-inventing in-home health monitoring, today announced that it has raised $14M in Series A funding, bringing the total capital raised to
Read More
The Combination of 5G and AI Will Transform Healthcare in 2021
Not many will disagree that the global pandemic has accelerated the use of technology in healthcare. With a healthcare system stressed to a breaking point, medical professionals have had to prioritize critical cases and increasingly turn to technology tools such as telemedicine and remote patient monitoring to manage the needs of their non-COVID patients.
As we begin to look beyond the pandemic, we will not only have the lessons of this time but improved tools to support the delivery of
Read More
Boston Scientific Acquires Remote Cardiac Monitoring Company Preventice Solutions for $1.2B
What You Should Know:
- Boston Scientific announces an agreement to acquire Preventice Solutions, a leading developer of mobile health solutions and remote monitoring services that connect patients and caregivers for $1.2B.
- The acquisition of external cardiac monitoring technologies and services providers will expand Boston Scientific’s rhythm management diagnostics portfolio and capabilities.
Boston
Scientific today announced that it has acquired
Preventice Solutions, Inc.,
a
Read More
2020’s Top 20 Digital Health M&A Deals Totaled $50B
Teladoc Health and Livongo Merge
The combination of Teladoc Health and Livongo creates a
global leader in consumer-centered virtual care. The combined company is
positioned to execute quantified opportunities to drive revenue synergies of
$100 million by the end of the second year following the close, reaching $500
million on a run-rate basis by 2025.
Price: $18.5B in value based on each share of Livongo
will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration
of
Read More
M&A: Philips Acquires Remote Cardiac Monitoring BioTelemetry for $2.8B
What You Should Know:
- Philips acquires BioTelemetry, a U.S. provider of
remote cardiac diagnostics and monitoring for $72.00 per share for an implied
enterprise value of $2.8 billion (approx. EUR 2.3 billion).
- With $439M in revenue in 2019, BioTelemetry annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors, AI-based data analytics, and services.
- BioTelemetry business is expected to deliver double-digit growth and improve its
Read More
Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know:
- Cardiopulmonary digital health company Eko raises $65M
in Series C funding to close the gap between virtual and in-person heart and
lung care.
- The latest round of funding will enable Eko to expand
in-clinic use of its platform of telehealth and AI algorithms for disease
screening and to launch a monitoring program for cardiopulmonary patients at
home.
Eko, a
cardiopulmonary digital
health company,
today announced $65 million in Series C funding led by
Read More